Colciago, R.R.; Chissotti, C.; Ferrario, F.; Belmonte, M.; Purrello, G.; Faccenda, V.; Panizza, D.; Canova, S.; Passarella, G.; Cortinovis, D.L.;
et al. Time to Next Treatment Following Sub-Ablative Progression Directed Radiation Therapy for Oligoprogressive Non-Small-Cell Lung Cancer. Curr. Oncol. 2024, 31, 6840-6852.
https://doi.org/10.3390/curroncol31110505
AMA Style
Colciago RR, Chissotti C, Ferrario F, Belmonte M, Purrello G, Faccenda V, Panizza D, Canova S, Passarella G, Cortinovis DL,
et al. Time to Next Treatment Following Sub-Ablative Progression Directed Radiation Therapy for Oligoprogressive Non-Small-Cell Lung Cancer. Current Oncology. 2024; 31(11):6840-6852.
https://doi.org/10.3390/curroncol31110505
Chicago/Turabian Style
Colciago, Riccardo Ray, Chiara Chissotti, Federica Ferrario, Maria Belmonte, Giorgio Purrello, Valeria Faccenda, Denis Panizza, Stefania Canova, Gaia Passarella, Diego Luigi Cortinovis,
and et al. 2024. "Time to Next Treatment Following Sub-Ablative Progression Directed Radiation Therapy for Oligoprogressive Non-Small-Cell Lung Cancer" Current Oncology 31, no. 11: 6840-6852.
https://doi.org/10.3390/curroncol31110505
APA Style
Colciago, R. R., Chissotti, C., Ferrario, F., Belmonte, M., Purrello, G., Faccenda, V., Panizza, D., Canova, S., Passarella, G., Cortinovis, D. L., & Arcangeli, S.
(2024). Time to Next Treatment Following Sub-Ablative Progression Directed Radiation Therapy for Oligoprogressive Non-Small-Cell Lung Cancer. Current Oncology, 31(11), 6840-6852.
https://doi.org/10.3390/curroncol31110505